Kim Kahn

Chewing missed estimates in his fourth quarter report and issued mixed guidance.

However, shares were sharply higher as investors focused on management's confident tone, highlighting expanding margins and strong cash generation.

And Sarepta Therapeutics is surging after reporting initial Phase 1 and 2 data for experimental treatments targeting two rare forms of muscular dystrophy.

And in other news of note, BlackRock CEO Larry Fink had some blunt advice for investors frustrated by limited redemptions in private credit funds.

Deal with it.

On the front page of the contract, you're investing in something that has less liquidity, he told the BBC's Big Boss interview podcast.

You have to accept that redemptions are going to be limited to 5% a quarter.

Those are the rules.

Live with it.

Fink also stressed that unlike the financial crisis, private credit does not pose a systemic risk, despite recent redemption pressure in some retail funds.

The financial crisis in 2007 was based on hidden leverage, gigantic leverage on balance sheets, he said.

This is not a leverage balance sheet problem.

While some retail investors are seeking to exit, Fink said institutional demand remains strong.

More people are trying to get in, he said, adding that its H-Lend fund saw more subscriptions than redemptions.

And senior leaders at Meta Platforms could earn hundreds of millions of dollars if the company reaches a $9 trillion valuation within five years.

Meta awarded new stock options to seven top executives, excluding CEO Zuckerberg.

The options vest only if the stock rises at least 88% by 2031.

Executives could capture the full payout if shares climb more than 500% over that period, according to a filing.

And join the elite community of real investors to unearth great investing ideas.

Just head to SeekingAlpha.com slash subscriptions.